ISTO Biologies

ISTO Biologies is a privately held orthobiologics company that specializes in regenerative medicine and bone healing solutions. The company was formed in 2016 through the merger of ISTO Technologies and Advanced Biologics, combining expertise in cell therapy and bone graft substitutes. ISTO Biologies offers a diverse portfolio of products, including the Magellan Autologous Platelet Separator System and the InQu Bone Graft Extender & Substitute, which are used in spinal fusion and orthopedic trauma surgeries. Their technology focuses on harnessing the body's natural healing potential through concentrated growth factors and advanced scaffolds. Headquartered in St. Louis, Missouri, the company serves a global market of surgeons and healthcare providers. In 2020, ISTO Biologies was acquired by Thompson Street Capital Partners to further accelerate its growth and product development.